Research and Development
Working to Improve Diversity in Clinical Trials
CSL Behring joins a consortium of leading companies to raise awareness of clinical trials for all.
Rev Up Your Biotech Career With the 4 'R's
Be ready, relentless, resourceful and resilient, Bill Mezzanotte, CSL Behring’s Head of R&D and Chief Medical Officer, tells …
Seeking Researchers in Bleeding Disorders
Applications are open for CSL Behring’s Heimburger Awards, which provide funding for coagulation research.
Harnessing the 'Spirit of Innovation'
CSL Behring opens its first Philadelphia lab at University City Science Center.
Accessing Early Innovation in Europe
Research initiative connects CSL Behring with early-stage biotech ventures.
Machine Learning and a Slippery Prognosis
A Google subsidiary invites data scientists to crowd-solve big problems, like predicting lung function decline in patients wi…
Three Quotes About an Unprecedented Year
When CSL Limited announced its end-of-year results, company leaders took stock of where we’ve been and where we’re headed.
Watch: Advice for Young Scientists
Our Chief Scientific Officer offers words of wisdom for-up-and coming researchers.
Celebrating Scientific Innovation in Philadelphia
CSL Behring-sponsored Nucleus Awards honor region’s groundbreakers.
CSL’s New Chief Scientific Officer
Dr. Andrew Nash has a lot on his plate, but he really wants to see your latest data.
Careful Steps Into a New Normal
One of CSL Behring's newest innovation centers in Bern, Switzerland, springs back to full life, with COVID-19 precautions in …